IRVINE, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in medical technologies to treat advanced cardiovascular disease, will host its 2005 Investor Conference at its headquarters in Irvine, California on Tuesday, November 29 and Wednesday, November 30, 2005. Opening the conference on the evening of November 29 will be Alain G. Cribier, MD, chief of cardiology at the Charles Nicolle Hospital in Rouen, France. Dr. Cribier’s presentation will be accessible the following afternoon, Wednesday, November 30, via archived webcast on the Edwards Lifesciences website at www.edwards.com/InvestorRelations/Presentations.htm.
Michael A. Mussallem, Edwards Lifesciences’ chairman and CEO, as well as other members of management, will speak to the attendees of the 2005 Investor Conference on Wednesday, November 30 beginning at 8:00 a.m. PST and concluding at approximately 1:30 p.m. PST. Steven F. Bolling, MD, professor of surgery, section of cardiac surgery at the University of Michigan in Ann Arbor, Michigan and Maurice E. Sarano, MD, cardiovascular diseases and internal medicine at the Mayo Clinic in Rochester, Minnesota will be guest speakers at the conference. Wednesday’s presentations will be available to all interested parties via live webcast on Edwards’ website at www.edwards.com/InvestorRelations/EventCalendar.htm. The webcast will also be archived after the conference concludes and available on Edwards’ website at www.edwards.com/InvestorRelations/Presentations.htm.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company’s global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT, and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office.
Edwards Lifesciences Corporation
CONTACT: Investors, David K. Erickson, +1-949-250-6826, or Media, Barry R.Liden, +1-949-250-5070, both of Edwards Lifesciences Corporation
Web site: http://www.edwards.com/
